Chief Commercial Officer and Board Member
IRVING, Texas - January 5, 2016 - Reata has enrolled its first patient with pulmonary hypertension associated with interstitial lung disease (PH-ILD) into
A seasoned development-stage biotechnology leader, C-suite executive and board public biotech board member. 28 years of diverse therapeutic area experience including Oncology, Hematology, rare diseases, Dermatology, Cardiovascular, Pulmonary Medicine, Neurology. Broad general management and functional area experience including drug manufacturing, business development, global commercial, corporate communications, investor relations. Significant exposure to drug development, clinical trial design and execution, regulatory strategy.
Anymail finder is trusted by tens of thousands of companies to provide accurate contact information to their Sales and Business Development teams.
If you’re looking to find the email of Dawn Bir at Reata Pharmaceuticals then you’ve come to the right place.
Wondering if it's dawn@reatapharma.com, dawn.bir@reatapharma.com, bir@reatapharma.com, or dbir@reatapharma.com? We have the answers for you.